Heidelberg Pharma AG (XTER:HPHA) Change In Inventory : €-6.51 Mil (TTM As of May. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Heidelberg Pharma AG Change In Inventory?

Heidelberg Pharma AG's change in inventory for the quarter that ended in May. 2024 was €-0.23 Mil. It means Heidelberg Pharma AG's inventory increased by €0.23 Mil from Feb. 2024 to May. 2024 .

Heidelberg Pharma AG's change in inventory for the fiscal year that ended in Nov. 2023 was €-5.90 Mil. It means Heidelberg Pharma AG's inventory increased by €5.90 Mil from Nov. 2022 to Nov. 2023 .

Heidelberg Pharma AG's Total Inventories for the quarter that ended in May. 2024 was €11.73 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Heidelberg Pharma AG's Days Inventory for the quarter that ended in May. 2024 was 799.09.

Inventory Turnover measures how fast the company turns over its inventory within a year. Heidelberg Pharma AG's Inventory Turnover for the quarter that ended in May. 2024 was 0.11.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Heidelberg Pharma AG's Inventory-to-Revenue for the quarter that ended in May. 2024 was 4.16.

Heidelberg Pharma AG Change In Inventory Historical Data

The historical data trend for Heidelberg Pharma AG's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heidelberg Pharma AG Change In Inventory Chart

Heidelberg Pharma AG Annual Data

Trend

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

Change In Inventory

Get a 7-Day Free Trial

-0.06

0.01

-0.52

-3.84

-5.90

Heidelberg Pharma AG Quarterly Data
	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24
Change In Inventory	Get a 7-Day Free Trial															0.04	-3.68	-1.59	-1.01	-0.23

Heidelberg Pharma AG Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in May. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-6.51 Mil.

Heidelberg Pharma AG (XTER:HPHA) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Heidelberg Pharma AG's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	11.612	/	1.326	*	365 / 4
	=	799.09

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Heidelberg Pharma AG's Inventory Turnover for the quarter that ended in May. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	1.326	/	11.612
	=	0.11

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Heidelberg Pharma AG's Inventory to Revenue for the quarter that ended in May. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	11.612	/	2.788
	=	4.16

Heidelberg Pharma AG Change In Inventory Related Terms

Thank you for viewing the detailed overview of Heidelberg Pharma AG's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Heidelberg Pharma AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Heidelberg Pharma AG (XTER:HPHA) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

HPHA:Germany

Address

Gregor-Mendel-Street 22, Ladenburg, DEU, 68526

Website

https://www.heidelberg-pharma.com

Heidelberg Pharma AG is a biopharmaceutical company. It is focused on oncology and develops the toxin Amanitin into cancer therapies using its proprietary Antibody Targeted Amanitin Conjugate (ATAC) technology platform and advances the biological mode of action of the toxin as a novel therapeutic principle. The proprietary lead candidate is HDP-101 which is a BCMA (B-cell maturation antigen) - ATAC for multiple myeloma. In addition, the company offers preclinical contract research services. It operates through the following business divisions: Customer Specific Research, Diagnostics, and TherapeuticS.

Executives

Prof. Dr. Andreas Pahl

Board of Directors

Heidelberg Pharma AG Headlines

No Headlines